1. Home
  2. FLOC vs EVO Comparison

FLOC vs EVO Comparison

Compare FLOC & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Flowco Holdings Inc.

FLOC

Flowco Holdings Inc.

HOLD

Current Price

$27.10

Market Cap

944.8M

Sector

Industrials

ML Signal

HOLD

Logo Evotec SE

EVO

Evotec SE

HOLD

Current Price

$3.00

Market Cap

934.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FLOC
EVO
Founded
1996
1993
Country
United States
Germany
Employees
1281
4553
Industry
Metal Fabrications
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
944.8M
934.1M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
FLOC
EVO
Price
$27.10
$3.00
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
1
Target Price
$28.50
$7.00
AVG Volume (30 Days)
607.9K
96.3K
Earning Date
05-06-2026
04-08-2026
Dividend Yield
1.31%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$22.92
$1.37
Revenue Next Year
$8.59
$10.05
P/E Ratio
$16.57
N/A
Revenue Growth
N/A
N/A
52 Week Low
$14.03
$2.31
52 Week High
$26.56
$4.80

Technical Indicators

Market Signals
Indicator
FLOC
EVO
Relative Strength Index (RSI) 71.94 47.30
Support Level $15.04 $2.88
Resistance Level N/A $3.78
Average True Range (ATR) 1.02 0.12
MACD 0.19 -0.03
Stochastic Oscillator 95.30 13.73

Price Performance

Historical Comparison
FLOC
EVO

About FLOC Flowco Holdings Inc.

Flowco Holdings Inc is a provider of production optimization, artificial lift, emissions management, and monetization solutions for the oil and natural gas industry. Its technologies include high-pressure gas lift (HPGL), conventional gas lift, plunger lift, and vapor recovery unit (VRU) solutions. The company operates in two reportable segments: Production Solutions, which includes rental services, and Natural Gas Technologies, which include service, gas compression parts, and equipment sales. Production Solutions: relates to rentals, sales, and services related to high-pressure gas lift, conventional gas lift, and plunger lift; including other digital solutions and methane abatement technologies, and has maximum revenue. It generates maximum revenue from the United States.

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

Share on Social Networks: